Sandoval David I. 4
4 · MAXCYTE, INC. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Sandoval David I.
GENERAL COUNSEL
Transactions
- Sale
Common Stock
2025-01-13$4.54/sh−4,466$20,272→ 41,447 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding due upon vesting of previously granted restricted stock units. Such "sale to cover" was automatically effected to satisfy tax withholding obligations and does not represent a discretionary trade by the Reporting Person.